A microprotein called adipogenin appears to play a key role in helping fat cells store lipid droplets—a phenomenon that's pivotal for metabolic health, a study co-led by UT Southwestern Medical Center researchers shows. ...
Nov 24, 2025
0
1
The liver plays a central role in storing and supplying energy to the body. In type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD, commonly referred to as fatty liver disease), mitochondria—the ...
Nov 21, 2025
0
0
Dr. Ann Coulter of Pennington Biomedical Research Center recently presented research on a novel nutritional supplement that targets fat cells to stimulate weight loss at the Bio on the Bayou conference in New Orleans.
Nov 12, 2025
0
0
Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat cells and may result in type 2 diabetes in people with obesity.
Nov 12, 2025
0
0
In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients with severe hypertriglyceridemia by more than 60%, according to a preliminary late-breaking science ...
Nov 10, 2025
0
0
A multidisciplinary research team has discovered that liver alterations associated with metabolic dysfunction–associated fatty liver disease (MASLD) can directly cause cognitive and neurological impairments, and that these ...
Oct 30, 2025
0
0
An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing toward more serious conditions, such as cirrhosis or liver ...
Oct 22, 2025
0
1
They've become as ubiquitous on British high streets as coffee shops—bubble tea outlets offering their Instagram-worthy drinks in countless flavor combinations. The Taiwanese beverage, a blend of black tea, milk, sugar ...
Oct 21, 2025
0
26
UF Health Cancer Center researchers have found a surprising culprit behind common health problems such as obesity, diabetes and fatty liver disease: silent genetic glitches in the blood system that occur naturally as people ...
Oct 14, 2025
0
2
Novo Nordisk said Thursday it was buying US biotech firm Akero Therapeutics, which is developing treatments for a number of metabolic diseases, for $4.7 billion.
Oct 9, 2025
0
0
